Development Technologies Corp Stock Performance
| DVTC Stock | USD 9.12 2.87 45.92% |
Development Technologies holds a performance score of 14 on a scale of zero to a hundred. The firm shows a Beta (market volatility) of -3.51, which means a somewhat significant risk relative to the market. As returns on the market increase, returns on owning Development Technologies are expected to decrease by larger amounts. On the other hand, during market turmoil, Development Technologies is expected to outperform it. Use Development Technologies total risk alpha, daily balance of power, as well as the relationship between the Daily Balance Of Power and price action indicator , to analyze future returns on Development Technologies.
Risk-Adjusted Performance
14 of 100
Weak | Strong |
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Development Technologies Corp are ranked lower than 14 (%) of all global equities and portfolios over the last 90 days. In spite of rather unfluctuating basic indicators, Development Technologies exhibited solid returns over the last few months and may actually be approaching a breakup point. ...more
Development |
Development Technologies Relative Risk vs. Return Landscape
If you would invest 375.00 in Development Technologies Corp on September 26, 2024 and sell it today you would earn a total of 537.00 from holding Development Technologies Corp or generate 143.2% return on investment over 90 days. Development Technologies Corp is currently generating 1.7474% in daily expected returns and assumes 9.4473% risk (volatility on return distribution) over the 90 days horizon. In different words, 84% of pink sheets are less volatile than Development, and 66% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Development Technologies Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Development Technologies' investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as Development Technologies Corp, and traders can use it to determine the average amount a Development Technologies' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.185
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | DVTC | |||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 9.45 actual daily | 84 84% of assets are less volatile |
Expected Return
| 1.75 actual daily | 34 66% of assets have higher returns |
Risk-Adjusted Return
| 0.19 actual daily | 14 86% of assets perform better |
Based on monthly moving average Development Technologies is performing at about 14% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Development Technologies by adding it to a well-diversified portfolio.
About Development Technologies Performance
By analyzing Development Technologies' fundamental ratios, stakeholders can gain valuable insights into Development Technologies' financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Development Technologies has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Development Technologies has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Pegasus Pharmaceuticals Inc. manufactures and provides an advanced ECG system for the non-invasive screening of heart pathologies. Pegasus Pharmaceuticals Inc. was founded in 1995 and is headquartered in Palm Beach Gardens, Florida. Development Technologies operates under Shell Companies classification in the United States and is traded on OTC Exchange.Things to note about Development Technologies performance evaluation
Checking the ongoing alerts about Development Technologies for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Development Technologies help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Development Technologies is way too risky over 90 days horizon | |
| Development Technologies appears to be risky and price may revert if volatility continues |
- Analyzing Development Technologies' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Development Technologies' stock is overvalued or undervalued compared to its peers.
- Examining Development Technologies' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Development Technologies' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Development Technologies' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Development Technologies' pink sheet. These opinions can provide insight into Development Technologies' potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Development Pink Sheet analysis
When running Development Technologies' price analysis, check to measure Development Technologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Development Technologies is operating at the current time. Most of Development Technologies' value examination focuses on studying past and present price action to predict the probability of Development Technologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Development Technologies' price. Additionally, you may evaluate how the addition of Development Technologies to your portfolios can decrease your overall portfolio volatility.
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like |